EPISENSE
We help people with epilepsy live a more predictable, safe, and fulfilling life.
We use artificial intelligence and precision medicine to support better clinical decisions.
EPISENSE is a precision medicine project that integrates genetic and clinical information to reduce uncertainty in epilepsy treatment. Our goal is simple and profound: that each patient receives the most appropriate treatment, in the shortest time possible.
What is EPISENSE?
EPISENSE is a precision medicine project in development, designed to support doctors and patients in one of the greatest challenges of epilepsy: finding the right treatment for each person.
Through artificial intelligence, we combine genetic and clinical data to generate personalized therapeutic recommendations, based on scientific evidence.
Behind the technology, there is a clear conviction: less trial and error, more quality of life.
Understanding the biological basis of each patient
Understanding how epilepsy impacts each person
Reduce uncertainty in treatment selection
Decisions backed by science, not intuition
The Problem
One in three epilepsy patients does not receive the optimal treatment.
This translates into avoidable seizures, adverse effects, and limited quality of life.
The Solution
We convert complex data into clearer decisions, so the focus returns to the patient.
The Impact
Less time without answers
Less trial and error, more precision
More peace of mind for patients and professionals
Scientific Validation
Genetic testing in epilepsy is validated and recommended by international clinical guidelines for complex cases.
EPISENSE relies on this scientific consensus to bring that knowledge to daily clinical practice.
Technology Stack
Biological basis of diagnosis
The real story of each patient
Models that learn from thousands of cases
Technology at the service of medical judgment
Interested in collaborating or investing?
EPISENSE is a growing project that combines science, technology, and human purpose. If you share the vision of improving the lives of people with epilepsy, we would love to talk.
Contact